Icahn School of Medicine at Mount Sinai Hematopathology

Topics

• Lymphoma Diagnosis and Treatment 41
• Acute Myeloid Leukemia Research 29
• Chronic Lymphocytic Leukemia Research 16
• Myeloproliferative Neoplasms: Diagnosis and Treatment 16
• Viral-associated cancers and disorders 16
• CAR-T cell therapy research 9
• Autoimmune and Inflammatory Disorders Research 8
• CNS Lymphoma Diagnosis and Treatment 8
• COVID-19 Clinical Research Studies 8
• Multiple Myeloma Research and Treatments 8
• Hematopoietic Stem Cell Transplantation 6
• Lung Cancer Diagnosis and Treatment 6

Most cited

1. International Consensus Classification of acute lymphoblastic leukemia/lymphoma.

   Virchows Archiv : an international journal of pathology · 2023 · 137 citations · Amy Duffield

2. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.

   Blood advances · 2021 · 207 citations · Alina Florea

3. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.

   Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021 · 198 citations · Bruce Petersen

4. Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.

   Blood · 2021 · 167 citations · Alina Florea

5. Venous and arterial thrombosis in patients with VEXAS syndrome.

   Blood · 2024 · 52 citations · Alina Florea

6. Unreliable Automated Complete Blood Count Results: Causes, Recognition, and Resolution.

   Annals of laboratory medicine · 2022 · 47 citations · Jerald Gong

7. FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation.